Browsing Category

64243 posts
Wonderful trip to Xiuwen in Guiyang

Wonderful trip to Xiuwen in Guiyang

BEIJING, Jan. 24, 2024 /PRNewswire/ — A news report from chinadaily.com.cn: jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”  …
BETT 2024: ViewSonic to Debut New EdTech Solutions for Effective and Personalized Learning Across All Education Levels

BETT 2024: ViewSonic to Debut New EdTech Solutions for Effective and Personalized Learning Across All Education Levels

BREA, Calif., Jan. 24, 2024 /PRNewswire/ — ViewSonic Corp., a global leader…
Vantage Australia revamps Indices product offering in 2024

Vantage Australia revamps Indices product offering in 2024

SYDNEY, Jan. 24, 2024 /PRNewswire/ — Award-winning multi-asset broker Vantage (or Vantage Markets), has…
Vantage revamps Indices product offering for 2024, making it one of the most competitive in the industry

Vantage revamps Indices product offering for 2024, making it one of the most competitive in the industry

PORT VILA, Vanuatu, Jan. 24, 2024 /PRNewswire/ — Award-winning multi-asset broker Vantage (or Vantage…
Hilton Hotels Across Malaysia Unveils 'Reign of the Dragon' Chinese New Year Celebrations

Hilton Hotels Across Malaysia Unveils 'Reign of the Dragon' Chinese New Year Celebrations

Embrace tradition and festivity with a diverse range of offerings, including exclusive…
SOFTSERVE BOLSTERS APAC COMMITMENT WITH NEW HEAD OF BANKING, FINANCIAL SERVICES, AND INSURANCE (BFSI)

SOFTSERVE BOLSTERS APAC COMMITMENT WITH NEW HEAD OF BANKING, FINANCIAL SERVICES, AND INSURANCE (BFSI)

Financial technology pioneer joins SoftServe with 25+ years of industry experience SINGAPORE,…
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne

Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne

HANGZHOU and SHAOXING, China, Jan. 24, 2024 /PRNewswire/ — Ascletis Pharma Inc.…